Simple workouts may ward off joint pain in acne drug users
NCT ID NCT07196787
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether a structured exercise program can prevent muscle and joint pain caused by the acne medication isotretinoin. Researchers will enroll 160 people aged 18-35 who are starting isotretinoin for the first time. Half will follow an 18-week exercise plan; the other half will not. The study measures pain levels and quality of life to see if exercise helps.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- exercise therapy
- What this could lead to
- If it works, this could give people on isotretinoin a simple, drug-free way to avoid painful side effects.
- What could go wrong
- This is a small, early-stage study with no blinding, so results may be biased. Exercise may not help everyone, and the program requires a significant time commitment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 160 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Mar 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 35 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * The participant is between the ages of 18-35, * Not having a regular exercise habit, * Starting Isotretinoin treatment for the first time. Exclusion Criteria: * Presence of any diagnosed rheumatologic disease, * The presence of any diagnosed neurological disease, * Having any diagnosed psychiatric illness, * Having a physical disability that prevents them from exercising for any reason.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Isotretinoin are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Usak University
RECRUITINGUşak, 64200, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.